Psilocybin and MDMA approved for medical use: TGA
Psychiatrists and patients will have to meet strict criteria to use the substances.
Patients with treatment-resistant depression or PTSD could soon gain access to psilocybin and MDMA through authorised psychiatrists following a surprise TGA decision.
Last week, the medicines watchdog announced it would classify medicines containing the psychedelic substances as controlled drugs (S8) for specific clinical use in treatment-resistant conditions.
